Company witnessed QoQ revenue decline of 12.25%, which is lowest in the last 3 years. (Source: Consolidated Financials)
Biocon Share Price
Biocon share price insights
Black Spinning Top was formed for Biocon
Stock gave a 3 year return of -19.7% as compared to Nifty Midcap 100 which gave a return of 96.13%. (as of last trading session)
Company's annual revenue growth of 35.25% outperformed its 3 year CAGR of 28.19%. (Source: Consolidated Financials)
Biocon Ltd. share price moved up by 0.98% from its previous close of Rs 309.25. Biocon Ltd. stock last traded price is 312.25
Share Price Value Today/Current/Last 312.25 Previous Day 309.25
Key Metrics
PE Ratio (x) | - | ||||||||||
EPS - TTM (₹) | - | ||||||||||
MCap (₹ Cr.) | - | ||||||||||
Sectoral MCap Rank | - | ||||||||||
PB Ratio (x) | - | ||||||||||
Div Yield (%) | - | ||||||||||
Face Value (₹) | - | ||||||||||
Beta Beta
| - | ||||||||||
VWAP (₹) | - | ||||||||||
52W H/L (₹) |
Biocon Share Price Returns
1 Day | N.A. |
1 Week | N.A. |
1 Month | N.A. |
3 Months | N.A. |
1 Year | N.A. |
3 Years | N.A. |
5 Years | N.A. |
Biocon Share Recommendations
Recent Recos
Current
Mean Recos by 17 Analysts
SellSellHoldBuyStrong
Buy
That's all for Biocon recommendations. Check out other stock recos.
Analyst Trends
Ratings | Current | 1 Week Ago | 1 Month Ago | 3 Months Ago |
---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 |
Buy | 3 | 3 | 4 | 4 |
Hold | 3 | 3 | 3 | 3 |
Sell | 3 | 3 | 2 | 2 |
Strong Sell | 3 | 3 | 3 | 3 |
# Analysts | 17 | 17 | 17 | 17 |
Biocon Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
Quarterly Topline Performance
Company witnessed QoQ revenue decline of 12.25%, which is lowest in the last 3 years. (Source: Consolidated Financials)Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 35.25% outperformed its 3 year CAGR of 28.19%. (Source: Consolidated Financials)
Quarterly | Annual Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Total Income 3,965.70 4,519.20 3,620.20 3,516.10 3,928.80 Total Income Growth (%) -12.25 24.83 2.96 -10.50 30.11 Total Expenses 3,417.00 3,420.20 3,134.00 3,066.20 3,143.30 Total Expenses Growth (%) -0.09 9.13 2.21 -2.45 9.55 EBIT 548.70 1,099.00 486.20 449.90 785.50 EBIT Growth (%) -50.07 126.04 8.07 -42.72 422.27 Profit after Tax (PAT) 135.50 660.00 125.60 101.40 313.20 PAT Growth (%) -79.47 425.48 23.87 -67.62 - EBIT Margin (%) 13.84 24.32 13.43 12.80 19.99 Net Profit Margin (%) 3.42 14.60 3.47 2.88 7.97 Basic EPS (₹) 1.13 5.52 1.05 0.85 2.62 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 56,070.70 52,042.80 20,394.00 18,522.30 14,443.80 Total Assets Growth (%) 7.74 155.19 10.11 28.24 18.47 Total Liabilities 30,795.90 29,554.00 10,924.00 10,014.70 7,060.70 Total Liabilities Growth (%) 4.20 170.54 9.08 41.84 28.72 Total Equity 25,274.80 22,488.80 9,470.00 8,411.70 7,383.10 Total Equity Growth (%) 12.39 137.47 12.58 13.93 10.08 Current Ratio (x) 0.99 1.45 2.19 1.81 1.33 Total Debt to Equity (x) 0.80 0.99 0.58 0.47 0.28 Contingent Liabilities 0.00 1,990.90 1,585.00 1,588.60 1,489.90 All figures in Rs Cr, unless mentioned otherwise
Insights
Decrease in Cash from Investing
Company has used Rs 1004.5 cr for investing activities which is an YoY decrease of 92.97%. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 2,953.90 1,852.50 1,176.60 1,159.70 1,283.10 Net Cash used in Investing Activities -1,004.50 -14,281.80 -1,699.10 -3,624.70 -1,558.90 Net Cash flow from Financing Activities -2,332.70 13,048.70 242.10 2,564.00 387.60 Net Cash Flow -380.40 641.10 -243.30 106.10 165.40 Closing Cash & Cash Equivalent 1,233.60 1,294.80 653.70 897.00 824.70 Closing Cash & Cash Equivalent Growth (%) -4.73 98.07 -27.12 8.77 25.09 Total Debt/ CFO (x) 5.33 9.59 4.17 3.07 1.47 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 5.16 2.58 7.69 9.83 11.15 Return on Capital Employed (%) 6.37 4.07 8.26 8.32 11.61 Return on Assets (%) 1.82 0.88 3.17 3.99 5.18 Interest Coverage Ratio (x) 4.27 6.89 32.29 20.66 18.68 Asset Turnover Ratio (x) 0.27 0.12 0.13 38.36 43.62 Price to Earnings (x) 31.06 53.76 62.11 66.67 43.48 Price to Book (x) 1.60 1.39 4.76 6.51 4.84 EV/EBITDA (x) 12.17 15.50 20.32 26.99 19.29 EBITDA Margin (%) 28.22 25.84 26.67 26.83 28.00
Peer Comparison
Biocon Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Midcap 100
Stock gave a 3 year return of -19.7% as compared to Nifty Midcap 100 which gave a return of 96.13%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated -19.7% return as compared to Nifty Pharma which gave investors 33.17% return over 3 year time period. (as of last trading session)
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Midcap 100
Stock gave a 3 year return of -19.7% as compared to Nifty Midcap 100 which gave a return of 96.13%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated -19.7% return as compared to Nifty Pharma which gave investors 33.17% return over 3 year time period. (as of last trading session)
See All Parameters
MF Ownership
500.69
Amount Invested (in Cr.)
1.69%
% of AUM
0.00
% Change (MoM basis)
SBI Balanced Advantage Direct-G
Hybrid: Dynamic Asset Allocation
299.18
Amount Invested (in Cr.)
1.01%
% of AUM
0.00
% Change (MoM basis)
295.17
Amount Invested (in Cr.)
0.78%
% of AUM
-5.93
% Change (MoM basis)
MF Ownership as on 30 April 2024
Biocon F&O Quote
Futures
Options
- Expiry
Price
310.40-3.25 (-1.04%)
Open Interest
9,75,0003,45,000 (35.38%)
Open High Low Prev Close Contracts Traded Turnover (₹ Lakhs) 315.00 317.40 309.00 313.65 3,889 30,373.07 Open Interest as of 24 Apr 2024
Corporate Actions
Biocon Board Meeting/AGM
Biocon Dividends
- Others
Meeting Date Announced on Purpose Details May 16, 2024 Apr 12, 2024 Board Meeting Audited Results & Final Dividend Feb 08, 2024 Jan 10, 2024 Board Meeting Quarterly Results Nov 30, 2023 Oct 27, 2023 POM - Nov 10, 2023 Oct 09, 2023 Board Meeting Quarterly Results Aug 11, 2023 May 23, 2023 AGM - Type Dividend Dividend per Share Ex-Dividend Date Announced on Final 30% 1.5 Jul 07, 2023 May 24, 2023 Final 10% 0.5 Jun 30, 2022 Apr 28, 2022 Final 10% 0.5 Jul 18, 2019 Apr 25, 2019 Final 20% 1.0 Jul 19, 2018 Apr 26, 2018 Final 10% 0.5 - May 16, 2024 All Types Ex-Date Record Date Announced on Details Bonus Jun 12, 2019 Jun 13, 2019 Apr 25, 2019 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Jun 15, 2017 Jun 17, 2017 Apr 27, 2017 Bonus Ratio: 2 share(s) for every 1 shares held Bonus Sep 11, 2008 Sep 12, 2008 Apr 22, 2008 Bonus Ratio: 1 share(s) for every 1 shares held
About Biocon
Biocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 37,056.52 Crore) operating in Pharmaceuticals sector. Biocon Ltd. key Products/Revenue Segments include Bio Pharmaceuticals, Other Operating Revenue, Waste and Sale of services for the year ending 31-Mar-2023. Show More
Executives
Auditors
- KM
Kiran Mazumdar Shaw
Executive ChairpersonSMSiddharth Mittal
Managing Director & CEOEVEric Vivek Mazumdar
Non Exe.Non Ind.DirectorRRRavi Rasendra Mazumdar
Non Exe.Non Ind.DirectorShow More - B S R & Co. LLP
Industry
Key Indices Listed on
Nifty Midcap 100, Nifty 200, Nifty 500, + 21 more
Address
20th K.M. Hosur Road,Electronics City,Bengaluru, Karnataka - 560100
More Details
FAQs about Biocon share
- 1. What's the Biocon share price today?Biocon share price was Rs 310.80 as on 03 Jun, 2024, 11:49 AM IST. Biocon share price was up by 0.51% based on previous share price of Rs. 310.85. In last 1 Month, Biocon share price moved up by 1.83%.
- 2. Who are peers to compare Biocon share price?Within Pharmaceuticals sector Biocon, Glenmark Pharmaceuticals Ltd., Ipca Laboratories Ltd., Gland Pharma Ltd., Ajanta Pharma Ltd., Syngene International Ltd., J B Chemicals & Pharmaceuticals Ltd., Laurus Labs Ltd., Aarti Industries Ltd., Piramal Pharma Ltd. and Alembic Pharmaceuticals Ltd. are usually compared together by investors for analysis.
- 3. What has been highest price of Biocon share in last 52 weeks?In last 52 weeks Biocon share had a high price of Rs 331.00 and low price of Rs 217.50
- 4. What are the returns for Biocon share?Return Performance of Biocon Shares:
- 1 Week: Biocon share price moved down by 1.32%
- 1 Month: Biocon share price moved up by 1.83%
- 3 Month: Biocon share price moved up by 12.22%
- 6 Month: Biocon share price moved up by 29.15%
- 5. Who is the CEO of Biocon?Siddharth Mittal is the Managing Director & CEO of Biocon
- 6. Who are the key owners of Biocon stock?Following are the key changes to Biocon shareholding:
- Promoter holding has not changed in last 9 months and holds 60.64 stake as on 31 Mar 2024
- Domestic Institutional Investors holding has gone up from 12.59 (30 Jun 2023) to 13.68 (31 Mar 2024)
- Foreign Institutional Investors holding have gone down from 9.52 (30 Jun 2023) to 5.63 (31 Mar 2024)
- Other investor holding has gone up from 17.25 (30 Jun 2023) to 20.05 (31 Mar 2024)
- 7. What is the CAGR of Biocon?The CAGR of Biocon is 20.04.
- 8. Should I buy, sell or hold Biocon?As per Refinitiv (erstwhile Thomson Reuters), overall mean recommendation by 17 analysts for Biocon stock is to Hold. Recommendation breakup is as follows
- 5 analysts are recommending Strong Buy
- 3 analysts are recommending to Buy
- 3 analysts are recommending to Hold
- 3 analysts are recommending to Sell
- 3 analysts are recommending Strong Sell
- 9. What is the PE & PB ratio of Biocon?The PE ratio of Biocon stands at 36.31, while the PB ratio is 1.47.
- 10. What is the market cap of Biocon?Biocon share has a market capitalization of Rs 37,128.56 Cr. Within Pharmaceuticals sector, it's market cap rank is 13.
- 11. Is Biocon giving dividend?An equity Final dividend of Rs 1.5 per share was declared by Biocon Ltd. on 24 May 2023. So, company has declared a dividend of 30% on face value of Rs 5 per share. The ex dividend date was 07 Jul 2023.
- 12. What are the Biocon quarterly results?On Consoldiated basis, Biocon reported a total income and loss of Rs 3965.70 Cr and Rs 135.50 respectively for quarter ending 2024-03-31. Total Income and profit for the year ending 2024-03-31 was Rs 15621.20 Cr and Rs 1022.50 Cr.
- 13. How can I quickly analyze Biocon stock?Biocon share can be quickly analyzed on following metrics:
- Stock's PE is 36.31
- Price to Book Ratio of 1.47
Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.